• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高磷血症和低磷血症的评估。

Assessment of hyperphosphatemia and hypophosphatemia.

作者信息

Bourke E, Yanagawa N

机构信息

Department of Medicine, Veterans Administration Medical Center, Brooklyn, New York.

出版信息

Clin Lab Med. 1993 Mar;13(1):183-207.

PMID:8462260
Abstract

Methodologic aspects including causes of factitious hyperphosphatemia and hypophosphatemia are summarized. The differential diagnosis of hyperphosphatemia is reviewed under its three broad causes: decreased glomerular filtration rate, increased exogenous or endogenous phosphate load, and increased renal tubular phosphate reabsorption. The differential diagnosis of hypophosphatemia is reviewed under its three broad causes: inadequate gastrointestinal input, excess phosphate losses, and transcellular shifts. The consequences of hyperphosphatemia and hypophosphatemia are outlined with a focus on pathophysiologic and clinicochemical sequelae. A laboratory perspective is emphasized in outlining management strategies.

摘要

总结了包括假性高磷血症和低磷血症病因在内的方法学方面。高磷血症的鉴别诊断根据其三大病因进行综述:肾小球滤过率降低、外源性或内源性磷酸盐负荷增加以及肾小管磷酸盐重吸收增加。低磷血症的鉴别诊断根据其三大病因进行综述:胃肠道摄入不足、磷酸盐过度丢失和跨细胞转移。概述了高磷血症和低磷血症的后果,重点是病理生理和临床化学后遗症。在概述管理策略时强调了实验室视角。

相似文献

1
Assessment of hyperphosphatemia and hypophosphatemia.高磷血症和低磷血症的评估。
Clin Lab Med. 1993 Mar;13(1):183-207.
2
Assessment of hypocalcemia and hypercalcemia.低钙血症和高钙血症的评估。
Clin Lab Med. 1993 Mar;13(1):157-81.
3
[Clinical aspect of recent progress in phosphate metabolism. Hyperphosphatemia and hypophosphatemia].[磷代谢近期进展的临床情况。高磷血症和低磷血症]
Clin Calcium. 2009 Jun;19(6):785-92.
4
Endocrine crises. Hypophosphatemia and hyperphosphatemia.内分泌危象。低磷血症和高磷血症。
Crit Care Clin. 1991 Jan;7(1):201-14.
5
The Causes of Hypo- and Hyperphosphatemia in Humans.人类低磷血症和高磷血症的病因
Calcif Tissue Int. 2021 Jan;108(1):41-73. doi: 10.1007/s00223-020-00664-9. Epub 2020 Apr 13.
6
Is tenofovir involved in hypophosphatemia and decrease of tubular phosphate reabsorption in HIV-positive adults?替诺福韦是否与HIV阳性成年人的低磷血症及肾小管磷重吸收减少有关?
J Infect. 2006 May;52(5):335-8. doi: 10.1016/j.jinf.2005.07.020. Epub 2005 Sep 19.
7
A clinical approach to common electrolyte problems: 3. Hypophosphatemia.常见电解质问题的临床处理方法:3. 低磷血症。
Can Med Assoc J. 1984 Jan 1;130(1):17-23.
8
The role of bone in phosphate metabolism.骨骼在磷酸盐代谢中的作用。
Mol Cell Endocrinol. 2009 Oct 30;310(1-2):63-70. doi: 10.1016/j.mce.2008.08.031. Epub 2008 Sep 6.
9
Relation of plasma phosphate concentration to renal tubular reabsorption of phosphate.血浆磷酸盐浓度与肾小管磷酸盐重吸收的关系。
Clin Sci. 1969 Aug;37(1):23-36.
10
Phosphate is a uremic toxin.磷酸盐是一种尿毒症毒素。
J Ren Nutr. 2008 Jan;18(1):27-32. doi: 10.1053/j.jrn.2007.10.007.

引用本文的文献

1
Fibroblast Growth Factor 23 (FGF 23) and intact parathyroid hormone (iPTH) as markers of mineral bone disease among Nigerians with non-diabetic kidney disease.成纤维细胞生长因子 23(FGF23)和全段甲状旁腺激素(iPTH)作为非糖尿病肾病患者矿物质骨病的标志物。
Afr Health Sci. 2022 Mar;22(1):344-351. doi: 10.4314/ahs.v22i1.42.